Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy

Tumor growth rate (TGR; percent size change per month [%/m]) is postulated as an early radio-graphic predictor of response to anti-cancer treatment to overcome limitations of RECIST. We aimed to evaluate the predictive value of pre-treatment TGR (TGR(0)) for outcomes of advanced non-small cell lung...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Li-na, Zhang, Xuanye, Li, Haifeng, Chen, Tao, Chen, Chen, Zhou, Yixin, Lin, Zuan, Du, Wei, Fang, Wenfeng, Yang, Yunpeng, Huang, Yan, Zhao, Hongyun, Hong, Shaodong, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863973/
https://www.ncbi.nlm.nih.gov/pubmed/33552993
http://dx.doi.org/10.3389/fonc.2020.621329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863973/
https://www.ncbi.nlm.nih.gov/pubmed/33552993
http://dx.doi.org/10.3389/fonc.2020.621329

Ejemplares similares